SCHEDULE: T. Rowe Price Reports Stake in QuidelOrtho

T. Rowe Price Investment Management, Inc. has updated its beneficial ownership filing for QuidelOrtho Corp., reporting a 2.6% stake.

Summary

• T. Rowe Price Investment Management, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of QuidelOrtho Corp. common stock.
• The filing indicates that T. Rowe Price Investment Management, Inc. now beneficially owns 1,743,563 shares of QuidelOrtho Corp. common stock.
• This represents 2.6% of the class of securities.
• The filing is an amendment (Amendment No. 6) and the date of the event requiring the filing is June 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports a change in beneficial ownership percentage without disclosing new strategic information or significant financial performance.

Positives

• T. Rowe Price Investment Management, Inc. continues to hold a significant stake in QuidelOrtho Corp., indicating ongoing investor confidence.
• The filing clearly states the number of shares and percentage of ownership, providing transparency to the market.

Negatives

• The filing does not provide any new financial performance data or strategic updates for QuidelOrtho Corp.

Risks

• The filing itself does not introduce new risks, but the underlying investment in QuidelOrtho Corp. is subject to the company's own inherent business and market risks.

Future Outlook

This filing is a report of beneficial ownership and does not contain forward-looking statements or guidance regarding QuidelOrtho Corp.'s future performance.

Management Comments

• T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

Industry Context

StockSavvy.ai notes that this filing is typical for institutional investors adjusting their holdings or reporting thresholds. It reflects ongoing portfolio management activities within the healthcare sector, where QuidelOrtho operates.

Comparison to Industry Standards

• Institutional ownership stakes in publicly traded companies within the healthcare diagnostics sector typically range from less than 1% to significant majority holdings, depending on the investor's strategy.
• A 2.6% stake, as reported by T. Rowe Price Investment Management, Inc., is a common level of investment for a large asset manager, indicating a passive or moderate active investment approach rather than a controlling interest.

Stakeholder Impact

• Shareholders: Increased transparency regarding institutional ownership, potentially influencing market perception.
• Management of QuidelOrtho Corp.: Awareness of significant institutional investor presence.

Next Steps

• T. Rowe Price Investment Management, Inc. will continue to monitor its investment in QuidelOrtho Corp. and may adjust its holdings based on market conditions and company performance.
• Future filings will be made if ownership levels change significantly.

Key Dates

Keywords

QuidelOrtho Corp, T. Rowe Price Investment Management, Schedule 13G, Beneficial Ownership, Investment Management, Equity Stake